Prof Alessandro Vannucchi - University of Florence, Florence, Italy
Prof Alessandro Vannucchi talks to ecancer at the 18th EHA Congress in Stockholm about a phase III clinical trial that examined the outcomes of treating myelofibrosis with ruxolitinib and the best available therapy.